← Leaderboards
Gadi Wollstein
University Of Pittsburgh At Pittsburgh
$5,521,866
Attributed
$6,270,010
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $859.4K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,270,010 · 4
By mechanism
R01$5,882,390 · 3
R21$387,620 · 1
Top collaborators
- Ian A Sigal4 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Dennis M. McNamara$9,751,044
- Arthur M Feldman$7,994,094
- Robert L Hendricks$15,975,328
- Maria Mori Brooks$44,871,550
- Rachel Hess$28,269,712
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoTissuesResponseGlaucomaMeasurementBrainResearch Project GrantsBiomechanicsPhysiologic Intraocular PressureOptic DiskCharacteristicsPredispositionBlindnessBlood VesselsFutureStructureRetinaOptic NerveElectroretinographyBaseOptical Coherence TomographyAxonAstrocytesAnimal Model
Grant awards (14)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model$589,166
R01 · FY2025 · EY · contact PI
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model$859,423
R01 · FY2024 · EY · contact PI
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model$779,786
R01 · FY2023 · EY · contact PI
Biomarkers of Early Experimental Glaucoma - Resubmission - 1$46,786
R01 · FY2023 · EY · contact PI
Biomarkers of Early Experimental Glaucoma - Resubmission - 1$1
R01 · FY2023 · EY · contact PI
Biomarkers of Early Experimental Glaucoma - Resubmission - 1$692,774
R01 · FY2022 · EY · contact PI
Biomarkers of Early Experimental Glaucoma - Resubmission - 1$693,760
R01 · FY2021 · EY · contact PI
Biomarkers of Early Experimental Glaucoma - Resubmission - 1$724,405
R01 · FY2020 · EY · contact PI
Interplay between intraocular and cerebrospinal fluid pressure effects on the optic nerve head in vivo$377,215
R01 · FY2018 · EY
Interplay between intraocular and cerebrospinal fluid pressure effects on the optic nerve head in vivo$375,339
R01 · FY2017 · EY
Interplay between intraocular and cerebrospinal fluid pressure effects on the optic nerve head in vivo$372,149
R01 · FY2016 · EY
Interplay between intraocular and cerebrospinal fluid pressure effects on the optic nerve head in vivo$371,586
R01 · FY2015 · EY · contact PI
Nanoparticles as OCT Contrast Agents$180,813
R21 · FY2010 · EY · contact PI
Nanoparticles as OCT Contrast Agents$206,807
R21 · FY2009 · EY · contact PI